1News 1News: your global news briefing, coming soon on iOS & Android
Coming Soon
Back to Business
Citizens reiterates Summit Therapeutics stock rating after AstraZeneca deal
Business September 30, 2026 at 9:20 AM

Citizens reiterates Summit Therapeutics stock rating after AstraZeneca deal

Investing.com
Read the full story at Investing.com
More Stories
Chart Of The Day: Are Hyperscalers The New 'Sovereigns?'
Business
Chart Of The Day: Are Hyperscalers The New 'Sovereigns?'
🇺🇸 Seeking Alpha 1m ago
AirJoule: Exciting Science, Decent Acquisition, But No Revenue Yet
Business
AirJoule: Exciting Science, Decent Acquisition, But No Revenue Yet
🇺🇸 Seeking Alpha 5m ago
Costamare Bulkers: Better Rates, Same Capital-Allocation Problem
Business
Costamare Bulkers: Better Rates, Same Capital-Allocation Problem
🇺🇸 Seeking Alpha 11m ago
1News
Your world briefing, in your pocket

Curated news from 12 countries and 10 languages. Coming soon on iOS and Android.

Coming soon on App Store Coming soon on Google Play